The 62 rating InvestorsObserver gives to Dare Bioscience Inc (DARE) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 77 percent of stocks in the Biotechnology industry, DARE’s 62 overall rating means the stock scores better than 62 percent of all stocks.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Dare Bioscience Inc Stock Today?
Dare Bioscience Inc (DARE) stock is trading at $2.34 as of 1:25 PM on Tuesday, Jan 19, a gain of $0.90, or 62.5% from the previous closing price of $1.44. The stock has traded between $1.41 and $2.68 so far today. Volume today is high. So far 26,044,216 shares have traded compared to average volume of 1,477,335 shares.
Click Here to get the full Stock Score Report on Dare Bioscience Inc (DARE) Stock.
